Laboratory-Treated Donor Natural Killer Cells and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Recurrent and/or Metastatic Ovarian Cancer - Contacts and Locations

Laboratory-Treated Donor Natural Killer Cells and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Recurrent and/or Metastatic Ovarian Cancer

This study is currently recruiting participants.

Study NCT00652899. Last updated on October 25, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00652899

Locations


United States, Minnesota
	Masonic Cancer Center at University of Minnesota	Recruiting
	Minneapolis, Minnesota, United States, 55455
	Contact: Clinical Trials Office - Masonic Cancer Center at University o 612-624-2620

Sponsors and Collaborators

Masonic Cancer Center, University of Minnesota

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Melissa A. Geller, MD	Masonic Cancer Center, University of Minnesota